Cargando…

Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom

Background: Management of benign biliary strictures (BBS) post bilioenteric anastomoses requires a multidisciplinary approach including surgical, radiological, and/or endoscopic input. Patients often need multiple hospital visits for treatment with the long-term possibility of restenosis. Convention...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaz, Osborne P, Al-Islam, Shofiq, Khan, Zahid A, Wilde, Neil, Lowe, Beverley, Magilton, Anna, Subar, Daren A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620329/
https://www.ncbi.nlm.nih.gov/pubmed/34849309
http://dx.doi.org/10.7759/cureus.19075
_version_ 1784605194838867968
author Vaz, Osborne P
Al-Islam, Shofiq
Khan, Zahid A
Wilde, Neil
Lowe, Beverley
Magilton, Anna
Subar, Daren A
author_facet Vaz, Osborne P
Al-Islam, Shofiq
Khan, Zahid A
Wilde, Neil
Lowe, Beverley
Magilton, Anna
Subar, Daren A
author_sort Vaz, Osborne P
collection PubMed
description Background: Management of benign biliary strictures (BBS) post bilioenteric anastomoses requires a multidisciplinary approach including surgical, radiological, and/or endoscopic input. Patients often need multiple hospital visits for treatment with the long-term possibility of restenosis. Conventionally BBS have been treated with serial percutaneous transhepatic biliary dilatations necessitating repeat procedures for drain exchange or removal. Surgery may become necessary in refractory strictures. In the last decade, there have been increasing reports of the use of biodegradable stents (BDS) in treating biliary strictures mainly to address the need for repeated procedures for drain exchange. Aim: This study aimed to report the early outcomes in patients with BBS treated with BDS. Methods: Retrospective analysis of prospectively collected data was performed in patients who had a bilioenteric anastomosis presenting with an anastomotic stricture and were intended to be treated with BDS. The primary endpoints reported were technical success (defined as a successful resolution of stricture on repeat cholangiogram) and clinical success (defined as the absence of repeated cholangitis). Clavien-Dindo (CD) grade of complication was reported. Results: Twelve patients presented with BBS and nine patients had BDS. Three patients were not considered suitable for BDS due to a non-traversable stricture and had surgery. The male-female ratio was 1:2. There was 100% technical and clinical success with one patient having stent migration not needing intervention. The procedure took an average of 45 min. In seven (77.7%) patients, it was safely performed under local anesthesia with sedation. Two patients preferred general anesthesia. There was no restenosis noted at a median follow-up of 11 months. Conclusion: The use of BDS in the treatment of BBS is a safe and effective procedure. Longer-term follow-up with multi-institutional reporting on a national database is needed to assess its long-term benefits.
format Online
Article
Text
id pubmed-8620329
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86203292021-11-29 Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom Vaz, Osborne P Al-Islam, Shofiq Khan, Zahid A Wilde, Neil Lowe, Beverley Magilton, Anna Subar, Daren A Cureus Radiology Background: Management of benign biliary strictures (BBS) post bilioenteric anastomoses requires a multidisciplinary approach including surgical, radiological, and/or endoscopic input. Patients often need multiple hospital visits for treatment with the long-term possibility of restenosis. Conventionally BBS have been treated with serial percutaneous transhepatic biliary dilatations necessitating repeat procedures for drain exchange or removal. Surgery may become necessary in refractory strictures. In the last decade, there have been increasing reports of the use of biodegradable stents (BDS) in treating biliary strictures mainly to address the need for repeated procedures for drain exchange. Aim: This study aimed to report the early outcomes in patients with BBS treated with BDS. Methods: Retrospective analysis of prospectively collected data was performed in patients who had a bilioenteric anastomosis presenting with an anastomotic stricture and were intended to be treated with BDS. The primary endpoints reported were technical success (defined as a successful resolution of stricture on repeat cholangiogram) and clinical success (defined as the absence of repeated cholangitis). Clavien-Dindo (CD) grade of complication was reported. Results: Twelve patients presented with BBS and nine patients had BDS. Three patients were not considered suitable for BDS due to a non-traversable stricture and had surgery. The male-female ratio was 1:2. There was 100% technical and clinical success with one patient having stent migration not needing intervention. The procedure took an average of 45 min. In seven (77.7%) patients, it was safely performed under local anesthesia with sedation. Two patients preferred general anesthesia. There was no restenosis noted at a median follow-up of 11 months. Conclusion: The use of BDS in the treatment of BBS is a safe and effective procedure. Longer-term follow-up with multi-institutional reporting on a national database is needed to assess its long-term benefits. Cureus 2021-10-27 /pmc/articles/PMC8620329/ /pubmed/34849309 http://dx.doi.org/10.7759/cureus.19075 Text en Copyright © 2021, Vaz et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiology
Vaz, Osborne P
Al-Islam, Shofiq
Khan, Zahid A
Wilde, Neil
Lowe, Beverley
Magilton, Anna
Subar, Daren A
Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
title Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
title_full Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
title_fullStr Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
title_full_unstemmed Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
title_short Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
title_sort bio-degradable stents: primary experience in a tertiary hepatopancreaticobiliary center in the united kingdom
topic Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620329/
https://www.ncbi.nlm.nih.gov/pubmed/34849309
http://dx.doi.org/10.7759/cureus.19075
work_keys_str_mv AT vazosbornep biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom
AT alislamshofiq biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom
AT khanzahida biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom
AT wildeneil biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom
AT lowebeverley biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom
AT magiltonanna biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom
AT subardarena biodegradablestentsprimaryexperienceinatertiaryhepatopancreaticobiliarycenterintheunitedkingdom